Preferred Medicine is a precision oncology company that is focused on providing a simple blood test aimed at providing early cancer detection. By combining the power of miRNA and AI technologies, as we pursue detecting the world’s most common cancers at high accuracy. The company’s goal is to widen access to cancer screening for all patients - helping to reduce emotional stress and healthcare costs, all while improving care, quality of life, and in many cases, saving lives. We are excited to continue the current development of our first product PREMIR, for patients with high-risk for breast cancer. PREMIR offers physicians a quick and simple early detection screening test, combined with our proprietary technology. Preferred Medicine is headquartered in Burlingame, CA, USA. It is supported by a leading global investor and AI technology company. For more information, please visit www.preferred-medicine.com